-
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
firstwordpharma
January 25, 2017
Intrexon Corporation (NYSE: XON) announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a clinical-stage company and pioneer in the development of AdenoVerse™ gene delivery technology.
-
Amatsigroup Acquires Disposable-Lab
contractpharma
January 22, 2017
Enhances capabilities in development services for injectable drug products
-
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
lilly
January 19, 2017
Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million.
-
Indicia Production Acquires METIS Biotechnologies
contractpharma
January 11, 2017
Flow cytometry technology developed by METIS will complement Indicia's current offering in microbiological analyses
-
Aurobindo Pharma to buy Portugal’s Generis for 135 mn euro
financialexpress
January 11, 2017
The combined entity will benefit from a robust pipeline covering all major molecules coming off patent in the next five years
-
Ipsen to acquire global oncology assets from Merrimack for $1.25bn
pharmaceutical-technology
January 11, 2017
French pharmaceutical company Ipsen has signed an agreement to acquire global oncology assets from US-based Merrimack Pharmaceuticals for $1.25bn.
-
Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine a
lilly
January 06, 2017
Eight new product lines and a fully integrated manufacturing and R&D site transfer to Elanco